-
Micropos Medical Ends the Year with a New Rental Order
Micropos Medical signs a rental agreement with another Spanish clinic. It is the ICO hospital in Badalona* that signs a “Try-Before-Buy” agreement to use the Raypilot System for its introduction […]
-
New research: Better Sexual Function After Radiation Compared to Surgery in Prostate Cancer
Prostate cancer is primarily treated with surgery or radiation. Both methods are equally effective in curing the cancer, but the extent of potential side effects varies. A long-term study on […]
-
New research: Five treatment sessions as effective as 39 for radiation therapy in prostate cancer
New research: Five treatment sessions as effective as 39 for radiation therapy in prostate cancer In mid-October, results were published from a British long-term follow-up study of 874 prostate cancer […]
-
First Raypilot System Order in the U.S
Micropos Medical AB announced that the company has received an order through its U.S. subsidiary, Micropos Medical Inc., to deliver a Raypilot® system to the Medical University of South Carolina […]
-
Groundbreaking research shows single-dose radiotherapy has very low side effects despite high doses
New research published in Red Journal shows that single-dose radiotherapy, enhanced by motion control and the Raypilot System, can deliver high doses with very low side effects. The study demonstrates this approach significantly improves patients’ quality of life by minimizing toxicity.
-
Årsredovisning 2023
Välkommen att ladda ner Årsredovisning 2023. Du hittar den genom att klicka på nyheten eller på vår Investor sida under Rapporter.
-
KALLELSE TILL ÅRSSTÄMMA I MICROPOS MEDICAL AB (PUBL)
Aktieägarna i Micropos Medical AB (publ), 556648-2310, kallas härmed till årsstämma onsdagen den 29 maj 2024 kl. 16.30, på Konferenslokal Pråmen, Göteborg, Adolf Edelsvärds Gata 11, Göteborg.
-
Emissionsmemorandum 2024
Göteborg, 2024-02-19 Välkommen att ladda ner Emissionsmemorandum 2024. Du hittar den genom att klicka på nyheten eller på vår Investor sida under Rapporter.
-
Micropos Medical genomför företrädesemission
Styrelsen i Micropos Medical AB har idag beslutat om att genomföra en företrädesemission för att finansiera bolagets fortsatta marknadssatsningar. Målsättningen för 2024 är att kraftigt kunna öka antalet behandlade patienter […]
-
Micropos Medicals VD Thomas Lindström blickar tillbaka på några av höjdpunkterna under året som gått
Pressmeddelande publicerat Onsdagen den 20:e December, 2023 Antalet behandlade patienter med Raypilot System ökarTotalt har 250 patienter behandlats med Raypilot sedan starten. Det är ett bra underlag.Under året har de […]
